Find the right fit for you - faster
Get tailored insights about working at OrganaBio in one quick step.
OrganaBio Snapshot
• VISION: To democratize access to critical and limited resources for cell therapy developers, catalyzing clinical translation and commercialization of life-altering and life-saving cures
• MISSION: To create a portfolio of tightly integrated cellular and manufacturing solutions that allow developers to rapidly advance their programs to clinical translation
• MISSION: To create a portfolio of tightly integrated cellular and manufacturing solutions that allow developers to rapidly advance their programs to clinical translation
OrganaBio was founded in 2018 by scientists and business leaders motivated to bring next generation regenerative medicine therapies to market. Since then, we have assembled a team of industry veterans, from scientists and engineers with years of bioprocess and therapeutic development experience to those versed in Quality Assurance, Quality Control, Regulatory Affairs, and successful business-building. Combined, we have over five centuries of experience in all areas necessary for success in regenerative medicine! Our team is passionate about expediting the development of novel cell and gene therapies, ultimately improving quality of life and/or saving lives for many. We truly believe that regenerative medicine is the future of medicine, and we work relentlessly to help our customers and partners bring their therapies to market.
HemaCenter , LLC, and GaiaGift, LLC are wholly owned subsidiaries of OrganaBio that procure adult and birth tissues, respectively, from consented donors. HemaCenter supplies OrganaBio with adult whole blood-derived starting materials, such as leukopaks, while GaiaGift supplies OrganaBio with birth tissues including placenta, umbilical cord, cord blood, and neonatal foreskin. OrganaBio in turn provides these tissue and blood products, or cellular derivatives thereof to cell therapy developers for the advancement of next-generation medicines.
HemaCenter , LLC, and GaiaGift, LLC are wholly owned subsidiaries of OrganaBio that procure adult and birth tissues, respectively, from consented donors. HemaCenter supplies OrganaBio with adult whole blood-derived starting materials, such as leukopaks, while GaiaGift supplies OrganaBio with birth tissues including placenta, umbilical cord, cord blood, and neonatal foreskin. OrganaBio in turn provides these tissue and blood products, or cellular derivatives thereof to cell therapy developers for the advancement of next-generation medicines.
